Teradyne Stock: Rerating Is Real, But Next Leg Depends On AI Test Intensity (NASDAQ:TER)

NodeGuardian · 2026-03-21T10:59:37+00:00

Teradyne has shifted its focus to AI testing and automation, enhancing its valuation. With growth in AI-driven solutions and margin expansion, the author recommends buying TER shares on dips due to ongoing demand.

NodeGuardian

2026-03-21 10:59:37

Abstract generation in progress

Teradyne has successfully shifted its business focus from cyclical mobile testing to AI infrastructure test and automation, leading to a premium valuation. The company’s growth in AI compute and memory testing through platforms like UltraFLEXplus and Magnum 7 drives margin expansion. Despite already realizing a substantial re-rating, the author rates TER a buy, suggesting patient accumulation on dips due to persistent AI-driven demand.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.